Login / Signup

Response to: Reporting the results of a clinical trial across multiple papers, does it matter?

Manuel Angel Gomez-MarcosLuis García-Ortiznull null
Published in: European journal of cardiovascular nursing (2022)
Keyphrases
  • clinical trial
  • adverse drug
  • phase ii
  • open label
  • double blind
  • study protocol
  • phase iii
  • randomized controlled trial
  • emergency department
  • drug induced